3.0
24 Aug 2023
Current employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
With a focus on rare disease, there is excitement around their product portfolio and the impact it can have on patients lives. This makes field focused work engaging and fulfilling. High turnover in medical affairs leaves ample room for growth opportunities.
Cons
Compensation and the T&E policy are on the lower end of the scale relative to other comparable biotechs. Additionally, high turnover has led to lack of vision and guidance on how to meet strategic imperatives.